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ABSTRACT 
Objective: The present study was conducted to formulate and characterize the thin film containing astaxanthin nanoemulsion (TF-ASN) using 
Hydroxypropylmethyl Cellulose (HPMC) polymer as a film matrix system. The stability studies in different storage conditions were also performed. 
Methods: Astaxanthin nanoemulsion (As-NE) was prepared by using self-nanoemulsifying method, followed by incorporation into the HPMC matrix 
system by solvent casting method to forming TF-ASN. Evaluation of TF-ASN was performed by physical and mechanical characterizations. Stability 
study was carried out in both of accelerated (temperature of 40±2 °C/75±5% RH) and non-accelerated (at ambient temperature) conditions. Assay 
of astaxanthin in individual TF-ASN was determined compared to pure astaxanthin. 
Results: TF-ASN had good physical and mechanical characteristics that suitable for intraoral administration. 
Conclusion: For the study of stability under different storage conditions, it was proven that nanoemulsion form was packed in a HPMC matrix could 
enhance the stability of the astaxanthin. 
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INTRODUCTION 
Carotenoids are associated with a number of health benefits, and 
epidemiological studies show an inverse relationship between 
cardiovascular disease and cancer that occurs with the habit of 
consuming high amounts of carotenoids contained in foods, such as 
fruits and vegetables. The biological mechanism of carotenoids is 
still unclear, but apart from provitamin-A activity, carotenoids show 
antioxidant characteristics that can affect cell growth regulation, and 
modulate gene expression and immune response [1, 2]. Astaxanthin 
is one of the natural carotenoids with strong antioxidant 
characteristics (super-antioxidant), has no activity like a vitamin A 
and is a group of xanthophyll. Astaxanthin is a fat-soluble pigment 
synthesized by plants and some types of algae [3, 4].  
To understand better the potential benefits of high consumption of 
carotenoids in food, or as food supplements, there are recent 
studies regarding the absorption, distribution, and metabolism of 
various types of carotenoids in human subjects [5]. The 
bioavailability of some carotenoids, which are highly lipophilic, is 
low. The value varies from less than 10% of raw vegetables to 
more than 50% in oil-containing preparations. Limitation in terms 
of dissolution in the gastrointestinal fluid is one of the causes of 
low bioavailability. Another factor that causes the limitation of 
absorption of these compounds is the saturation of carotenoids to 
enter into micelles formed by bile in the gastrointestinal tract at 
high doses [6]. Increased bioavailability of carotenoids after 
administration together with fat is due to the conjugation of 
carotenoids into micelles of the bile salt. Factor that causes low 
astaxanthin bioavailability is due to the degradation of astaxanthin 
in the gastrointestinal tract and the possibility of astaxanthin 
experiencing first pass metabolism. A study of pharmacokinetics 
and the presence of a mechanism of degradation via first pass 
metabolism were carried out by Choi et al., which stated that the 
hepatic and gastrointestinal astaxanthin elimination extraction 
ratio were 0.490 and 0.901, respectively [7]. The value of the 
elimination extraction ratio ranges between 0 and 1 where the 
ratio value closes to 1 indicates that the drug is eliminated by the 
intended organ. 
The film dosage form is chosen to deliver the intraoral small dose of 
active substances because: a) has a relatively larger surface area 
than the tablet so that it is easier to wet and finally the 
disintegration and dissolution process of the film will be faster, b) 
more flexible so that it is not easily fragile and brittle like tablets 
when transportation, handling, until storage by patients becomes 
easier [8], and (c) with the use of mucoadhesive materials will 
increase the contact time so that the time for absorption of active 
substances increases [9]. 
In increasing stability and absorption of astaxanthin, encapsulation of 
astaxanthin was carried out in a nanometer-sized lipid carrier system. 
With this form, astaxanthin will be protected from degrading enzyme 
conditions and allow increasing transcellular (intracellular, passing 
through cells) absorption in particles less than 50-100 nm and 
paracellular (intercellular, passing through the edge of the cell). 
Generally, high molecular weight active substances are absorbed via 
the transcellular route. Hydrophilic molecules will pass the 
paracellular route while lipophilic molecules will pass through the 
transcellular route [10, 11]. This nanometer-sized carrier system will 
be developed using the Self-Nanoemulsifying Drug Delivery System 
(SNEDDS) method. Through this method, the nanocarrier-forming 
material will spontaneously produce a nanometer-sized globule if the 
material is dispersed in the appropriate conditions. After that, As-NE 
was packaged into the thin film dosage form by using HPMC polymer 
with the target for delivery of astaxanthin via intraoral route. With this 
strategy, our hypothesis is the stability and bioavailability of 
astaxanthin can be increased. This research is part of a series of 
studies that use natural polymers as film-making polymers. 
Differences in types and concentrations of polymers will affect the film 
mechanical properties. Previous study, we have conducted a 
comparative study that investigates the effect of natural polymers 
sodium alginate and gelatin on the film characteristics.  
This research was intended to develop a new astaxanthin delivery 
system to optimize the astaxanthin therapy. This research is a 
further research on the development of As-NE that has been 
successfully developed in previous study [12]. In this study, As-NE 
was prepared by using self nanoemulsifying method, where thin film 
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was prepared by using solvent casting method with combination 
between polymer and plasticizer. Both physical and mechanical 
evaluations of TF-ASN were performed including film organoleptic, 
film thickness, folding resistance, weight uniformity, film 
disintegration time, tensile strength, percent elongation, and film 
morphology. At the end of the study, the effectiveness of the dosage 
form in protecting the stability of astaxanthin was proven by the 
stability test compared to pure astaxanthin. 
MATERIALS AND METHODS 
Materials 
Astaxanthin (Astareal®L10) was purchased from Fuji Chemical 
Industries (Japan). Sunflower oil was purchased from Jan Dekker 
International (Netherland). Polyoxy-35-castor oil (Kolliphor®RH40) 
was purchased from BASF (Indonesia). Polyethylene Glycol 400 
(PEG 400) was purchased from Merck (Indonesia). 
Hydroxypropylmethyl cellulose (Pharmacoat® 606) was purchased 
from Shinetsu Chemical, Co., LTD (Japan). Poly (butyl methacrylate, 
(2-dimethylaminoethyl) methacrylate, methyl methacrylate) 1:2:1 
(Eudragit® E PO) was purchased from Evonik Industries (Thailand). 
All other chemicals used were of pharmaceutical grade. 
Methods 
Preparation of As-NE 
Four milligram astaxanthin was dissolved in 1 gram of oil phase 
containing sunflower oil, kolliphor®RH40, and PEG 400 with the 
ratio of 1:8:1, respectively. Then, the mixture was mixed for 30 min 
using magnetic stirrer (IKA®C-MAG HS7), followed by sonication for 
1 h (Krisbow®). Nanoemulsion will be formed after addition 
deionized water until 20 gram of solution.  
Optimization of thin film preparation 
In this study, HPMC was used as thin film forming polymers, with 
PEG 400 as plasticizer. Design of experiment for optimization both 
of polymers and plasticizer concentrations that were able to 
produce the best thin layer preparation were carried out by using 
Design-Expert® Version 12 Software with Simple Lattice Design 
method. Thin film was formed by pouring wet mixture into the flat 
and clean surface petri dish in diameter of 10 cm and dried for 48 h 
at ambient temperature. After dried, film thickness and film 
disintegration time were evaluated. The designs of experimental 
from the software are given in table 1. 
  
Table 1: Experimental designs of thin film preparation 
Formula Components (%, w/v) 
HPMC PEG 400 Deionized water 
F1 2.70 1.00 Adjust to 100% 
F2 2.70 1.00 
F3 8.00 0.11 
F4 4.03 0.78 
F5 5.35 0.55 
F6 5.35 0.55 
F7 8.00 0.11 
F8 6.67 0.33 
 
Preparation of TF-ASN 
As-NE containing 0.02% (w/w) of astaxanthin was added slowly 
into the mixture of optimized polymers matrix system according to 
table 1 and 0.04% (w/v) of Eudragit® E PO (in 10% (v/v) of Ethanol 
96%). The final mixing was done by using magnetic stirrer (IKA®C-
MAG HS7) in 100 rpm for 1 hour. Thin film was formed by pouring 
wet mixture into the flat and clean surface petri dish in diameter of 
10 cm and dried for 48 h at ambient temperature. Then, the TF-ASN 
was cut into the size of 3x3 cm2. 
Physical and mechanical characterizations of TF-ASN 
Organoleptic, film thickness and weight uniformity 
Organoleptic including color, odor, and clarity of thin film was 
visually observed. Film thickness was carried out by using 
micrometer (Mitutoyo®) at three different locations on the film. 
Meanwhile, weight uniformity of thin film was determined by 
weighing 6 pieces of thin film (with size of 3x3 cm2) using analytical 
balance (Mettler Toledo XS204). It is important to know these 
parameters because directly related to the accuracy of doses in the 
film.  
Folding resistance of TF-ASN 
Folding resistance of TF-ASN was determined by repeated folding of 
the film at the same place till the film breaks. The number of time the 
film is folded without breaking is computed as the folding resistance 
value [8]. 
Film disintegration time 
Film disintegration time was determined visually in a petri dish 
containing 10 ml of phosphate buffer pH 6.8 at 37 °C where the 
container was shaken in every 10 s. Disintegration time is the time 
at which the film begins to break or collapse. The disintegration time 
of a good thin film is less than 60 s [13]. 
Mechanical stress tests: tensile strength and percent elongation 
Mechanical stress tests of TF-ASN were performed by using 
Universal testing machine (Oriented UCT-5T). Dry film was cut into 
uniform sized pieces using sharp bladed cutting mold. Film (with 
area exposed to stress of 25 mm x 4 mm) was sandwiched between 
two machine jaws. Load was given to the film gradually (at a speed 
of 30 mm/minute) and automatically until the film shredded. Test 
was carried out at 23 °C and 50% relative humidity. Tensile strength 
is calculated by the applied load at rupture divided by the cross-
sectional area of the film. Percent elongation is defined as strain of 
the film. Strain is basically the deformation of strip divided by 
original dimension of the sample.  
Film morphology 
Film morphology of TF-ASN was examined by Scanning Electron 
Microscopy (SEM). Sample was sized according to the specimen 
container, followed by smearing with silver paste at several points 
before the sample was placed. Sample was dried at 20 °C. The 
sample was putted into the fine coat in voltage condition of 1.2 kV, 
ampere of 6-7.5 mA, and air pressure of 0.2 torr for 4 min to obtain a 
sample with a thickness about 400 Å. 
Stability study of TF-ASN 
Accelerated stability study was performed by refers to the ICH Q1A 
Guideline [14]. TF-ASN was packed into the glass bottle and then 
stored at ambient temperature and in the climatic chamber with 
temperature of 40±2 °C/75±5% RH for 6 mo at intervals of 0; 0.25; 
0.5; 0.75; 1; 2; 3; and 6 mo. Assay of astaxanthin were determined by 
dissolving TF-ASN (with size of 3x3 cm2) in volumetric flask 
containing 10 ml of phosphate buffer pH 6.8 for 30 min. Then, the 
absorbance was measured by UV-Visible Spectrophotometer 
(GenesysTM 10S) at the maximum wavelength of 472 nm. Assay of 
astaxanthin in TF-ASN was calculated by estimating the astaxanthin 
content in individual film.  
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RESULTS AND DISCUSSION 
Self-nanoemulsifying dosage forms are anhydrous homogenous 
liquid mixtures consisting of oil, surfactant, drug, and co-surfactant, 
which spontaneously form oil-in-water nanoemulsion upon dilution 
with water under gentle stirring [15, 16]. The illustration of As-NE 
structure was described in fig. 1 below. Adding surfactant and co-
surfactant into systems enhances drug dissolution and formulation 
dispersibility during dilution with aqueous medium of GIT. During 
dilution with water, active substance dissolves in oil phase and/or 
surfactant, which forms a film between oil and water phase [15]. The 
appropriate type and ratio of oil phase, surfactant and co-surfactant 
are critical parameters in formation of nanoemulsion. Based on our 
previous study, the best ratio between sunflower oil as oil phase, 
Kolliphor®RH40 as surfactant, and PEG 400 as co-surfactant were 
1:8:1, respectively. As-NE had droplets size in the nano-range (10-20 
nm) with polydispersity index was less than 0.5, while zeta potential 
value was more than-20 mV [12]. 
In the preliminary study, before formulation of the astaxanthin 
nanoemulsion into the polymer matrix system, optimization of 
polymer and plasticizer concentrations were carried out by using 
Design-Expert® Version 12 Software with Simple Lattice Design 
method. This software is a tool to find out the optimal variations 
between polymer and plasticizer concentrations in thin film 
preparation. The software will produce 8 experimental designs. 
Critical evaluations including film disintegration time and film 
thickness were carried out to find the best thin film characteristics. 
These parameters were simple parameters that related to the 
quality of the film and can be quantified. The results of evaluation in 
the preliminary study of thin film matrix system are given in table 2. 
The best characteristic of thin film was determined by using Simplex 
Lattice Design Modeling. The results of data analysis from the model 
are presented in fig. 2. 
 
 





[B]      [C] 
Fig. 2: Data analysis of thin film optimization using Simplex Lattice Design modeling. [A]: Desirability value; [B]: Film thickness prediction 
value; [C]: Film disintegration time prediction value 
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Table 2: The results of preliminary study on optimization of polymer matrix system 
Parameters Formula 
Film thickness (mm) F1 F2 F3 F4 
0.32±0.002 0.33±0.002 0.58±0.003 0.38±0.001 
F5 F6 F7 F8 
0.40±0.002 0.42±0.002 0.56±0.002 0.48±0.001 
Film disintegration time (s) F1 F2 F3 F4 
64.83±0.55 66.27±0.56  62.10±0.50 64.10±0.28 
F5 F6 F7 F8 
63.53±0.30  63.43±0.35 64.63±0.28 48.43±0.35 
*) Values are given as the mean±standard deviation (n=3). 
 
Based on the contour plots in fig. 2, it can be seen that effects of 
concentration polymer and plasticizer. The higher of polymer 
concentration, the longer of the film disintegration time needed, as 
well as the increasing of film thickness. Contrary to the effects of PEG 
on film thickness and disintegration time, where the higher of PEG 
concentration, the thinner of the film produced and the faster of the 
film disintegrated. The concentration of polymer is important factor in 
development of thin film. The integrity of fast dissolving oral film is 
dependent upon selection of polymer nature and its concentration. 
Different polymers are employed to modulate diverse properties of 
films [17, 18]. Polyethylene glycol (PEG) also has a good film forming 
properties either alone or in combination with other polymers [19]. 
The disintegration rate of the polymer is decreased by increasing the 
molecular weight and its concentration of polymer film matrix system 
[20, 21]. In thin film development, mechanical properties such as 
tensile strength and percent elongation are improved by adding 
plasticizer to the formulations [20]. Mechanical property of thin film is 
plasticizer concentration dependent [21]. The proper selection of the 
plasticizer is very important. The improper selection may cause 
cracking and splitting of the film [20, 22]. 
From the desirability value (1.000) in fig. 2A confirmed that mixture 
of HPMC and PEG 400 with film thickness around of 0.520833 mm 
and film disintegration time around of 49.2222 s was chosen for the 
next trial. Desirability value is the value from zero (outside of the 
limits) to one (at the goal). Desirability is simply a mathematical 
method to find the optimum (closed to one) [23]. So, it can be 
concluded that for the mixture contains of 6.67% (w/v) HPMC with 
0.33% (w/v) PEG 400 (F8) was the best combination polymer 
matrix system for preparation of TF-ASN. 
 
Table 3: Physical and mechanical properties of TF-ASN 
Parameters Observation/Results 
Film organoleptic  Orange, clear, and odorless 
Film thickness (mm)* 0.45±0.02 
Folding resistance (times) >300 
Weight Uniformity/sheet 3x3 cm (mg)* 203.4±0.2 
Film disintegration time (s)* 59.67±1.5 
Tensile strength (MPa)* 7.13±1.31 
Percent elongation (%)* 5.53±1.64 
*Values are given as mean±standard deviation (n=3). 
 
The film properties containing astaxanthin nanoemulsion prepared 
by using F8 are presented in table 3. In this study, films prepared 
using 10 mm petri dish in diameter showed good weight 
homogeneity. Folding resistance of all films were more than 300 
times, which indicates that the film had good flexibility. All films 
showed the disintegration time around 60 s, which related to easily 
of drugs released from the matrix system [13]. The weight variation 
is generally determined to ensure that each film contains the 
consistent amount of a drug without significant deviation. A large 
variation in weight signifies the inefficiency of the method applied 
and high chances are there for non-uniformity in drug content [24].  
The intraoral film must be flexible, soft, elastic, but must be strong 
enough against stress condition in the oral cavity [18, 25]. 
Mechanical properties of films can be defined in terms of percent 
elongations and tensile strength [26, 27]. It has been known that soft 
and weak polymers exhibit low tensile strength and low elongation 
at break; whereas the hard and tough polymer has a high tensile 
strength and high elongation at break [28]. The concentration and 
types of the polymers are largely responsible for producing a film 
having good mechanical strength and integrity [29]. HPMC is one of 
the non-ionic polymers with moderate mucoadhesive properties 
that stable at pH 3.0 to 11.0. Generally, the concentrations of HPMC 
used in the film formulation are between 2-20% [18]. Therefore, 
HMPC was chosen as a film-making polymer because of its stability 
and mucoadhesive properties. 
From the results in table 3, it was confirmed that TF-ASN was a 
flexible, weak, and soft film. Such characteristics are suitable for our 
drug delivery targeting via intraoral. With such characteristics, the 
thin film will be more comfortable for patient’s use, especially 
supported by the mucoadhesive characteristic of HPMC which 
makes the contact time of TF-ASN with the oral mucosa become 
longer. Visual observation of TF-ASN was done by observing the 
organoleptic. TF-ASN had orange color, odorless, smooth surface 
and transparent (fig. 3), but based on the morphological result by 
SEM (fig. 4), it was found that the surface of the film had many holes, 
which correlate to the weak nature of film due to small tensile 
strength value.  
 
 
Fig. 3: The visual observation of TF-ASN 
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Fig. 4: The morphology of TF-ASN with magnification of 50 
times. Red circle showed the holes in the film surface 
 
As a natural antioxidant, astaxanthin can easily be degraded by 
thermal or oxidative processes during storage or application. 
Astaxanthin is a highly unsaturated molecule and thus it is highly 
sensitive to high temperature, light, and oxidative conditions which 
possesses less activity [30, 31]. In this study, we had proven the 
effectiveness of our astaxanthin’s carrier/dosage form through the 
stability testing and comparing them with stability of pure 
astaxanthin. Pure astaxanthin was chosen as a comparator to prove 
that the dosage form developed was able to increase the stability of 
astaxanthin. 
The assay of astaxanthin in TF-ASN was measured periodically 
during the 6 mo of the study and the results are shown in fig. 5. The 
stability profile of astaxanthin in TF-ASN was however higher than 
those of the pure astaxanthin. This demonstrated that the 
nanoemulsion preparation loaded into HPMC matrix system 
protects the astaxanthin from thermal degradation and could 
potentially be used for enhancing the stability of the compounds. 
Stability profile of astaxanthin was also carried out under non-
accelerated storage conditions at ambient temperature during the 6 
mo of the study. It is demonstrated that after 6 mo, the assay of 
astaxanthin in TF-ASN was also higher than that of the pure 
astaxanthin. The stability profiles between TF-ASN in ambient 
temperature compared to the accelerated condition were no 
different, while the pure astaxanthin stability profiles were different. 
It can be concluded that TF-ASN was showed a temperature-
independent protection profile. One of the advantages of 
nanoemulsion is improving the stability of the therapeutic agents 
[16]. When astaxanthin is incorporated into the nanoemulsion 
system, it will dissolve in the oil phase and enters to the core of 
micelles system, which thermodynamically stable [32]. The right 
combination between surfactant and co-surfactant will protect the 
core of the micelles from environment [15, 16]. In addition, HPMC 
matrix could provide additional protective layers for the compound 




Fig. 5: Stability profile of astaxanthin in TF-ASN compared to pure astaxanthin. [A]: samples were stored at ambient temperature; [B]: 
samples were stored in the climatic chamber with temperature of 40±2 °C/75±5%RH 
 
CONCLUSION 
In summary, good physical and mechanical properties of thin film 
containing astaxanthin nanoemulsion were successfully developed 
using HPMC polymer. Flexible and soft film characteristics were 
suitable for intraoral use. For the study of stability under different 
storage conditions, it was proven that nanoemulsion form was 
packaged in a HPMC matrix could enhance the stability of the 
astaxanthin.  
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